Clinical Trial Update: Prospective Tacrolimus Pharmacokinetics Study in Pediatric Living Donor Liver Transplantation [Phase 4]

View source ↗

Summary

This update reports a Phase 4 prospective pharmacokinetics study of tacrolimus in pediatric living-donor liver transplant recipients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Transplantation

Drugs mentioned

• Prograf (Tacrolimus)

Snippet

Sponsor: Cliniques universitaires Saint-Luc- Université Catholique de Louvain | Conditions: Pediatric Liver Transplantation | Phase 4 | Status: UNKNOWN